| Ms Julie Ann Gemma, CRNA | |
|
1 Reverie Ln, Lincoln, RI 02865-4968 | |
| (401) 640-9480 | |
| Not Available |
| Full Name | Ms Julie Ann Gemma |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 1 Reverie Ln, Lincoln, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811932486 | NPI | - | NPPES |
| 110119590A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN239463 (Massachusetts) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | APRN01464 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it "this year's Snuggie".
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have now uncovered the details behind the molecule's effects.
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
› Verified 8 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it "this year's Snuggie".
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have now uncovered the details behind the molecule's effects.
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
› Verified 8 days ago
| Entity Name | Coastal Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932175684 PECOS PAC ID: 7113029257 Enrollment ID: O20070221000057 |
News Archive
A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it "this year's Snuggie".
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have now uncovered the details behind the molecule's effects.
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
› Verified 8 days ago
| Entity Name | Lawrence Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467699918 PECOS PAC ID: 4082770136 Enrollment ID: O20090225000707 |
News Archive
A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it "this year's Snuggie".
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have now uncovered the details behind the molecule's effects.
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
› Verified 8 days ago
| Entity Name | Matrix Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700028032 PECOS PAC ID: 8820136377 Enrollment ID: O20091210000301 |
News Archive
A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it "this year's Snuggie".
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have now uncovered the details behind the molecule's effects.
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
› Verified 8 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043711914 PECOS PAC ID: 2860688728 Enrollment ID: O20180329001196 |
News Archive
A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it "this year's Snuggie".
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have now uncovered the details behind the molecule's effects.
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Julie Ann Gemma, CRNA 1 Reverie Ln, Lincoln, RI 02865-4968 Ph: (401) 640-9480 | Ms Julie Ann Gemma, CRNA 1 Reverie Ln, Lincoln, RI 02865-4968 Ph: (401) 640-9480 |
News Archive
A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it "this year's Snuggie".
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have now uncovered the details behind the molecule's effects.
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
› Verified 8 days ago
Michael Paul Audette, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 17 E Butterfly Way, Lincoln, RI 02865 Phone: 401-723-3127 | |
Keith E Macksoud, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1817 Old Louisquisset Pike, Lincoln, RI 02865 Phone: 401-727-2443 Fax: 401-729-3476 |